Bloom Annual Report 2023

It is with great honor and excitement that I share Bloom Public Health’s 2023 annual report with you. We are so proud to showcase our achievements and core projects executed in the year 2023.
Every day, we are inspired to fulfill our mission, which is to provide the most trusted, timely, reliable, scalable, suitable, and sustainable services in the areas of supply chain management, pharmaceutical quality systems, laboratory strengthening and diagnostics, and policy for public health in Africa, and we have kept at it, taking one step at a time.
Foreseeing the potential for the transformation and revolution of the pharmaceutical manufacturing and laboratory space in Africa, Bloom Public Health embarked on specific projects to catalyze change.
These projects include the World Bank-funded IMPACT project, the pharmacity project, and the laboratory projects, to mention a few. Through the IMPACT project, five selected pharmaceutical manufacturers in Nigeria have received technical assistance towards the attainment of WHO prequalification for their antimalarials. Attaining this global standard will guarantee the manufacture of safe, quality-assured, and efficacious antimalarial medicines and also increase access to these medicines.

A host of pharmaceutical manufacturers have also been trained through the IMPACT project’s capacity-building workshops organized during the course of the year.
The Pharmacity Project, a Bloom Public Health initiative, is a compact modern-day pharmaceutical industrial estate that brings together pharmaceutical companies of various sizes, service providers, and companies providing support services to co-locate and share infrastructure. This strategic pharmaceutical intervention strives to tackle Nigeria’s unmet needs for both demand and supply of medicines by increasing medicine and health product manufacturing capacity.
Through strategic partnerships, Bloom Public Health is changing the narrative and ensuring that consistently reliable and GLP-compliant test results are generated by each laboratory in Nigeria and Africa.
Through our Laboratory and Diagnostics Strengthening initiatives, we have successfully partnered with various reputable organizations in Nigeria, where we have offered capacity-building workshops and trainings, accreditation services, and adequate support for laboratory analysis of consumer and health-related products.

I want to extend my profound appreciation to all our partners who have displayed a high level of trust in our technical capabilities and have worked with us over the years.
Bloom Public Health will continue to renew its commitment to revolutionize the pharmaceutical manufacturing, supply chain management, laboratory, and diagnostics space in Africa, taking one step at a time, one country at a time, starting with the countries we have a footprint in: Nigeria, Rwanda, Cameroon, Botswana, and Zambia.

Prof. Chimezie Anyakora
CEO, Bloom Public Health